Tradestie Institutional Equity Comparison Engine

ABEO vs CALI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABEO Overall Edge

ABEO Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abeona Therapeutics Inc. Common Stock (ABEO) driven by superior Valuation, Growth & Margin, Options & Structure while CALI counters with relative strength in Momentum & Technical. Fundamentally, ABEO trades at 18.7x Forward P/E with -186.1% operating margin (+2745.0% YoY revenue) versus CALI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro) against CALI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABEO
ABEO 18.7x vs CALI N/M Fwd P/E
Growth & Margin Winner ABEO
Op Margin -186.1% vs N/A ยท YoY +2745.0% vs N/A
Momentum & Technical Winner CALI
1Y -42.4% vs -0.8% ยท 52W Pos 6% vs 28%
Options & Structure Winner ABEO
BREAKDOWN (27th %ile IV) vs UNCLASSIFIED (N/A IV)
ABEO NASDAQ
Abeona Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.42
-1.22% 1D
Market Cap $167.4M
1M Return -45.86%
1Y Return -42.38%
Forward P/E 18.7x
Unified AI Score
49.9 / 100 HOLD
Tech 60.0 Fund 61.0 Flow 67.0 Mom 55.0
CALI NASDAQ
BlackRock ETF Trust II iShares Short-Term California Muni Active ETF
Institutional Equity
$50.14
+0.1% 1D
Market Cap N/A
1M Return +-0.0%
1Y Return -0.76%
Forward P/E N/M
Unified AI Score
53.0 / 100 HOLD
Tech 65.0 Fund 52.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABEO -42.38% CALI -0.76% Spread: +41.62 pp (CALI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABEO TTM Op. Margin: -186.1% CALI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABEO vs CALI. Trailing 12-month operating profitability (ABEO -186.1% vs CALI N/A) and valuation multiples (ABEO 18.7x vs CALI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABEO (7) vs CALI (3)
Institutional Metric ABEO CALI Criterion Row Winner
Market Capitalization Scale $167.4M N/A Larger Scale ABEO
Trailing P/E Ratio Valuation 18.7x N/M Lower Multiple ABEO
Forward P/E Ratio Valuation 18.7x N/M Lower Multiple ABEO
Revenue Growth (YoY) Growth +2745.0% N/A Higher Growth ABEO
Operating Margin (TTM) Profitability -186.1% N/A Higher Margin ABEO
Net Profit Margin Profitability -160.3% N/A Higher Margin ABEO
Return on Equity (ROE) Capital Efficiency -42.1% N/A Higher ROE ABEO
52-Week Range Position Momentum 6% ($2โ€“$8) 28% ($50โ€“$51) Stronger Trend CALI
Beta / 30D Volatility Risk Regime 0.60ฮฒ ยท 149% Vol 0.01ฮฒ ยท 1% Vol Lower Realized Risk CALI
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 53.0 / 100 (HOLD) Higher Composite CALI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABEO vs CALI Buy Guide
ABEO BREAKDOWN
71d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 27th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABEO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CALI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CALI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABEO nor CALI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.